Implication of First-Line Antiretroviral Therapy Choice on Second-Line Options.
Meloni ST, Onwuamah CK, Agbaji O, Chaplin B, Olaleye DO, Audu R, Samuels J, Ezechi O, Imade G, Musa AZ, Odaibo G, Okpokwu J, Rawizza H, Mu'azu MA, Dalhatu I, Ahmed M, Okonkwo P, Raizes E, Ujah IAO, Yang C, Idigbe EO, Kanki PJ.
Meloni ST, et al. Among authors: ujah iao.
Open Forum Infect Dis. 2017 Nov 2;4(4):ofx233. doi: 10.1093/ofid/ofx233. eCollection 2017 Fall.
Open Forum Infect Dis. 2017.
PMID: 29255731
Free PMC article.